A Content Analysis of GLP-1 Receptor Agonist Health Claims and Safety Information on Philippine Social Media (2025–2026)

Social media discourse on glucagon-like peptide-1 (GLP-1)-based medicines, including semaglutide and tirzepatide, has expanded rapidly alongside growing public interest in their use for weight management. However, little is known about the accuracy, safety information, and commercial promotion of such online discourse in the Philippines. This study aimed to (1) describe GLP-1-related social media content surfaced in the Philippines from January 2025 to January 2026, (2) evaluate the accuracy of claims relative to current U.S. Food and Drug Administration prescribing information, and (3) determine the extent of safety information presented. Using an exploratory cross-sectional quantitative content analysis, 38 publicly available posts from YouTube, Facebook, and TikTok were identified through purposive keyword searches and analyzed using a structured coding tool covering drug name, creator type, claim accuracy, adverse drug reaction information, contraindications, dosage, commercial intent, and social-media engagement. The sample was dominated by news and media sources (50.0%). Most posts mentioned semaglutide (80.3%) and tirzepatide (42.1%). Fifty percent of posts were coded as fully accurate, 44.7% as partially accurate, and 5.3% as inaccurate. Safety information was inconsistently reported, with the lowest Safety Information Score observed among the sampled TikTok posts. Definite or partial commercial intent was identified in 28.9% of posts. Given the small purposive sample, platform-level differences should be interpreted descriptively. These findings support clearer health-care-professional safety communication, strengthened regulatory surveillance and consumer guidance, and platform-level contextual labeling of GLP-1-related content.

Authors

Institutions

Publication Details

Journal
Journal of Consumer Health on the Internet
Published
2026-11-12
DOI
https://doi.org/10.1080/15398285.2026.2735764
Primary Topic
Social Media in Health Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Content Analysis of GLP-1 Receptor Agonist Health Claims and Safety Information on Philippine Social Media (2025–2026)

Zypher Jude G. Regencia
Journal of Consumer Health on the Internet
Social Media in Health Education
article

A Content Analysis of GLP-1 Receptor Agonist Health Claims and Safety Information on Philippine Social Media (2025–2026)

Zypher Jude G. Regencia
article en

Abstract

Social media discourse on glucagon-like peptide-1 (GLP-1)-based medicines, including semaglutide and tirzepatide, has expanded rapidly alongside growing public interest in their use for weight management. However, little is known about the accuracy, safety information, and commercial promotion of such online discourse in the Philippines. This study aimed to (1) describe GLP-1-related social media content surfaced in the Philippines from January 2025 to January 2026, (2) evaluate the accuracy of claims relative to current U.S. Food and Drug Administration prescribing information, and (3) determine the extent of safety information presented. Using an exploratory cross-sectional quantitative content analysis, 38 publicly available posts from YouTube, Facebook, and TikTok were identified through purposive keyword searches and analyzed using a structured coding tool covering drug name, creator type, claim accuracy, adverse drug reaction information, contraindications, dosage, commercial intent, and social-media engagement. The sample was dominated by news and media sources (50.0%). Most posts mentioned semaglutide (80.3%) and tirzepatide (42.1%). Fifty percent of posts were coded as fully accurate, 44.7% as partially accurate, and 5.3% as inaccurate. Safety information was inconsistently reported, with the lowest Safety Information Score observed among the sampled TikTok posts. Definite or partial commercial intent was identified in 28.9% of posts. Given the small purposive sample, platform-level differences should be interpreted descriptively. These findings support clearer health-care-professional safety communication, strengthened regulatory surveillance and consumer guidance, and platform-level contextual labeling of GLP-1-related content.

Journal of Consumer Health on the Internet
University of the Philippines Manila (PH), De La Salle University (PH)
Good health and well-being
Social Media in Health Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon